Grzybowski Andrzej, Bajoriūnaitė Aušrinė, Žemaitienė Reda
Department of Ophthalmology, University of Warmia and Mazury, 10-719, Olsztyn, Poland.
Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, 61-553, Poznan, Poland.
Ophthalmol Ther. 2025 Nov;14(11):2735-2752. doi: 10.1007/s40123-025-01250-8. Epub 2025 Sep 26.
Postoperative endophthalmitis (POE) is a rare but severe intraocular infection that can lead to irreversible vision loss if not promptly and adequately treated. This condition occurs when infecting organisms enter the eye through direct inoculation, such as during intraocular surgery, penetrating trauma, or contiguous spread from adjacent tissues. The risk of infection has also increased with the growing use of intravitreal pharmacotherapy, such as treatments with antivascular endothelial growth factor agents. Sources of infection in POE include bacteria colonized on the patient's eyelid margin and conjunctiva, healthcare personnel, surgical instruments, solutions, and intraocular lenses. Microbial trends indicate that Staphylococcus epidermidis (S. epidermidis) and unspecified coagulase-negative Staphylococci (CoNS) are the most prevalent pathogens. Fungal endophthalmitis, commonly caused by Candida albicans, primarily affects patients who are immunocompromised, including those with human immunodeficiency virus (HIV), malignancies, diabetes mellitus, immunosuppressive medication or intravenous drug use, solid organ transplantation, lung disease, and renal insufficiency. The management of POE relies on the prompt initiation of appropriate empirical antibiotic therapy targeting the most common causative organisms. However, antimicrobial resistance (AMR) has become one of the most pressing global health challenges, with the World Health Organization (WHO) recognizing AMR as one of the top ten global public health threats. The goal is to ensure the judicious use of antibiotics while preventing AMR development. A critical preventive strategy in ophthalmology is the use of antiseptics before interventional eye procedures. Studies have shown that the application of effective antiseptic agents-such as povidone-iodine (PVP-I), chlorhexidine (CHX), hypochlorous acid (HOCl), polyhexamethylene biguanide (PHMB), and picloxydine dihydrochloride can significantly reduce the incidence of postoperative infections, thereby minimizing the risk of endophthalmitis. This article reviews the importance, effectiveness, and benefits of preoperative antiseptic use in ophthalmology, emphasizing their role in preventing infections without encouraging antibiotic resistance. In addition to their preventive role, it also examines the potential therapeutic applications of these same agents in the management of ocular infections.
术后眼内炎(POE)是一种罕见但严重的眼内感染,如果不及时、充分治疗,可导致不可逆转的视力丧失。当感染性生物体通过直接接种进入眼睛时,就会发生这种情况,比如在眼内手术、穿透性外伤期间,或从相邻组织连续扩散时。随着玻璃体内药物治疗(如抗血管内皮生长因子药物治疗)的使用增加,感染风险也有所上升。POE的感染源包括定植在患者眼睑边缘和结膜上的细菌、医护人员、手术器械、溶液和人工晶状体。微生物趋势表明,表皮葡萄球菌(S. epidermidis)和未明确的凝固酶阴性葡萄球菌(CoNS)是最常见的病原体。真菌性眼内炎通常由白色念珠菌引起,主要影响免疫功能低下的患者,包括那些感染人类免疫缺陷病毒(HIV)、患有恶性肿瘤、糖尿病、使用免疫抑制药物或静脉注射毒品、进行实体器官移植、患有肺部疾病和肾功能不全的患者。POE的治疗依赖于迅速开始针对最常见病原体的适当经验性抗生素治疗。然而,抗菌药物耐药性(AMR)已成为最紧迫的全球健康挑战之一,世界卫生组织(WHO)将AMR列为全球十大公共卫生威胁之一。目标是确保合理使用抗生素,同时防止AMR的产生。眼科的一项关键预防策略是在介入性眼科手术前使用防腐剂。研究表明,应用有效的防腐剂——如聚维酮碘(PVP-I)、氯己定(CHX)、次氯酸(HOCl)、聚六亚甲基双胍(PHMB)和盐酸吡咯克定——可显著降低术后感染的发生率,从而将眼内炎的风险降至最低。本文回顾了眼科术前使用防腐剂的重要性、有效性和益处,强调它们在预防感染而不助长抗生素耐药性方面的作用。除了预防作用外,本文还探讨了这些相同药物在眼部感染治疗中的潜在应用。